A Mounjaro increase should follow a review of benefit, side effects and the treatment plan. A calendar, a stronger appetite or a promotional price is not enough information to make that decision yourself.
Know what the schedule does and does not mean
The adult schedule starts at 2.5 mg weekly, moving to 5 mg after four weeks. Further increases use 2.5 mg steps, with at least four weeks at the current dose. The listed adult maintenance doses are 5, 10 and 15 mg. These are the boundaries of the licensed schedule, not a personal instruction to keep increasing until the highest dose is reached.
When a provider displays all strengths in a row, it can look like a shopping sequence. Read it as a set of available prescriptions. Your next order should match the clinician's decision, including any decision to stay at a dose while response or tolerability is assessed.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: UK Summary of Product Characteristics
Bring a record that answers useful questions
Write down when each injection was taken, whether any doses were missed, and when symptoms began. Add your weight trend and how the treatment affects eating, drinking and ordinary activities. Record new medicines, including short courses. This creates a timeline: a symptom that started before an increase is different information from one that appeared just afterwards.
Useful questions include: what benefit are we assessing; what would make us hold the current dose; and when should I contact you before the next planned review? Ask for the agreed next step in writing so the prescription, order and your own notes match.
Sources: NICE: Prescribing, reviewing and stopping tirzepatide
Describe appetite without using it as a dose calculator
A statement such as 'I feel hungrier this week' is worth discussing, but it is only one observation. Describe whether meals remain manageable, whether you are skipping food because of nausea, and whether the overall trend has changed. An isolated day cannot establish the cause of a change or tell you which strength to use.
Avoid treating the absence of hunger as the sole measure of success. Ask the clinician how the treatment plan supports adequate nutrition and sustainable activity as well as weight change. If food intake has become difficult, say so clearly instead of presenting that difficulty as evidence that the medicine is working well.
Sources: NICE: Overweight and obesity management: medicines and surgery; NHS: Overweight and obesity in adults
An interruption needs its own discussion
The leaflet has a rule for a single missed dose: take it within four days, otherwise skip it and resume on the usual day. A longer interruption, uncertain injection or restart after troublesome symptoms deserves individual advice. Do not infer a restart strength from the number of pens left at home.
Give the prescriber the last actual injection date and strength, not merely the date of your last order. Mention why treatment stopped. Delivery timing, illness and adverse effects raise different practical questions. Arrange the plan before purchasing another strength.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet
Include affordability before the prescription changes
If a proposed dose changes the repeat price, ask what the full next supply will cost and whether clinical contact is included. Explain a budget limit before a gap develops. The useful outcome is an agreed treatment plan you can follow, not an improvised lower amount from a stronger pen.
Do not count clicks, extract residual liquid or share pens to make a purchase last longer. Ask the pharmacy to explain the device and supply quantity. A cost comparison should help you compare legitimate services for the prescribed dose.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet; General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online
Questions, answered.
Should I increase after every four weeks?
Four weeks is the minimum interval for later increases, not a requirement to increase. Follow the prescriber's reviewed plan.
Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: UK Summary of Product Characteristics
What if the pharmacy has only a different strength?
Ask the prescriber and dispensing pharmacy to resolve the supply. A stock substitution is not a dose-conversion instruction.
Sources & further reading
Original sources for this guide. Source checks are not independent clinical review.
- Mounjaro KwikPen: UK Summary of Product CharacteristicsEli Lilly / electronic medicines compendium · Accessed 19 November 2026
- Mounjaro KwikPen: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
- Prescribing, reviewing and stopping tirzepatideNICE · Accessed 19 November 2026
- Overweight and obesity management: medicines and surgeryNICE · Accessed 19 November 2026
- Overweight and obesity in adultsNHS · Accessed 19 November 2026
- How to keep safe when getting medicines or treatment onlineGeneral Pharmaceutical Council and UK health organisations · Accessed 19 November 2026
